Public behaviour and understanding most important weapon against COVID-19: Responding to the Government’s announcement about new three-tiered lockdown rules in England, Danny Mortimer, chief executive of the NHS Confederation, said: “We welcome the much-needed clarity the Government’s new three-tiered system will hopefully give the public on their local restrictions and freedoms. There now needs to […]
Read More… from Public behaviour and understanding essential
Severe COVID-19 infection linked to overactive immune cells: Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases. When infected with the SARS-CoV-2 coronavirus, many people experience mild and moderate symptoms, but for some people infection can be severe or fatal. Scientists are urgently seeking […]
Read More… from Severe COVID-19 infection linked to overactive immune cells
High risk of deep vein thrombosis and pulmonary embolism in patients with COVID-19: In a systematic review of the worldwide published data on “Venous thromboembolism (VTE) in COVID-19 patients”, Cihan Ay, Stephan Nopp, and Florian Moik from the Department of Medicine I, Clinical Division of Haematology and Haemostaseology, now for the first time, provide an in-depth […]
Read More… from COVID-19: deep vein thrombosis and pulmonary embolism
Never too late to fight back against pandemic: By Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization One million people have now been lost to COVID-19 and many more are suffering because of the pandemic. This milestone is a difficult moment for the world but there are glimmers of hope that encourage us now […]
Read More… from Never too late to fight back against pandemic
WHO: Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 […]
Read More… from Rapid $5 tests for low & middle income countries
People with bone, joint and muscle pain saw their symptoms worsen during lockdown – according to new research from the University of East Anglia. A new study shows that the majority of people with musculoskeletal pain reported increased symptoms – as the nation adhered to new government restrictions designed to stop the spread of the […]
Trudie Lobban MBE is the Founder & Trustee of Arrhythmia Alliance (The Heart Rhythm Charity), Founder of Syncope Trust and Reflex anoxic Seizure group (STARS & STARS-US) and Founder & CEO of Atrial Fibrillation Association (AFA). She is recognised as a world expert at representing patients and their carers as well as working closely with all […]
Read More… from Arrhythmia Alliance Heart Rhythm Virtual Congress 2020
Rare and less common cancer charities come together to tackle pandemic’s impact through inspirational new fundraiser, 20for20. Twenty charities representing people affected by rare and less common cancers have joined forces in a major new fundraising campaign. Brought together by national bone and soft tissue cancer charity Sarcoma UK, the event is a response to […]
Arrhythmia Alliance (A-A) Heart Rhythm Congress 2020 (launching 27 September) — hosted on the purpose-built Arrhythmia Alliance Virtual Conference Centre — will see world-renowned experts review, debate, and discuss key issues in the field of electrophysiology. Highlights of the first virtual A-A HRC2020, which will be a combination of recorded and live presentations, include: A joint […]
New tool outsmarts COVID-19 virus to help vaccine development: Melbourne researchers have developed a tool to monitor mutations that make it difficult to develop coronavirus (COVID-19) vaccines and drugs. Ensuring treatments remain effective as the virus mutates is a huge challenge for researchers. The powerful new tool harnesses genomic and protein information about the virus […]
Read More… from Monitoring mutations to help vaccine development